Logo image of RE21.DE

REDEIA CORP SA (RE21.DE) Stock Fundamental Analysis

FRA:RE21 - Deutsche Boerse Ag - ES0173093024 - Common Stock - Currency: EUR

18.96  -0.07 (-0.37%)

Fundamental Rating

4

Overall RE21 gets a fundamental rating of 4 out of 10. We evaluated RE21 against 17 industry peers in the Electric Utilities industry. There are concerns on the financial health of RE21 while its profitability can be described as average. RE21 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year RE21 was profitable.
In the past year RE21 had a positive cash flow from operations.
In the past 5 years RE21 has always been profitable.
Each year in the past 5 years RE21 had a positive operating cash flow.
RE21.DE Yearly Net Income VS EBIT VS OCF VS FCFRE21.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

RE21 has a Return On Assets of 2.44%. This is in the lower half of the industry: RE21 underperforms 64.71% of its industry peers.
Looking at the Return On Equity, with a value of 7.15%, RE21 is doing worse than 70.59% of the companies in the same industry.
With a Return On Invested Capital value of 4.57%, RE21 is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
RE21 had an Average Return On Invested Capital over the past 3 years of 5.40%. This is below the industry average of 9.46%.
Industry RankSector Rank
ROA 2.44%
ROE 7.15%
ROIC 4.57%
ROA(3y)3.9%
ROA(5y)4.28%
ROE(3y)11.26%
ROE(5y)14.12%
ROIC(3y)5.4%
ROIC(5y)6%
RE21.DE Yearly ROA, ROE, ROICRE21.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 23.11%, RE21 belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
RE21's Profit Margin has declined in the last couple of years.
RE21 has a better Operating Margin (44.44%) than 94.12% of its industry peers.
RE21's Operating Margin has declined in the last couple of years.
RE21 has a better Gross Margin (102.40%) than 100.00% of its industry peers.
RE21's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 44.44%
PM (TTM) 23.11%
GM 102.4%
OM growth 3Y-3.37%
OM growth 5Y-3.68%
PM growth 3Y-12.8%
PM growth 5Y-8.28%
GM growth 3Y0.16%
GM growth 5Y0.22%
RE21.DE Yearly Profit, Operating, Gross MarginsRE21.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RE21 is destroying value.
RE21 has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for RE21 has been increased compared to 5 years ago.
Compared to 1 year ago, RE21 has a worse debt to assets ratio.
RE21.DE Yearly Shares OutstandingRE21.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RE21.DE Yearly Total Debt VS Total AssetsRE21.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

RE21 has an Altman-Z score of 1.34. This is a bad value and indicates that RE21 is not financially healthy and even has some risk of bankruptcy.
RE21 has a Altman-Z score (1.34) which is in line with its industry peers.
A Debt/Equity ratio of 1.00 indicates that RE21 is somewhat dependend on debt financing.
RE21 has a Debt to Equity ratio of 1.00. This is in the better half of the industry: RE21 outperforms 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACC0.81
WACC5.63%
RE21.DE Yearly LT Debt VS Equity VS FCFRE21.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

RE21 has a Current Ratio of 1.18. This is a normal value and indicates that RE21 is financially healthy and should not expect problems in meeting its short term obligations.
RE21's Current ratio of 1.18 is amongst the best of the industry. RE21 outperforms 82.35% of its industry peers.
A Quick Ratio of 1.14 indicates that RE21 should not have too much problems paying its short term obligations.
RE21 has a better Quick ratio (1.14) than 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.14
RE21.DE Yearly Current Assets VS Current LiabilitesRE21.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

The earnings per share for RE21 have decreased strongly by -51.42% in the last year.
RE21 shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.24% yearly.
RE21 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.76%.
The Revenue has been decreasing by -4.50% on average over the past years.
EPS 1Y (TTM)-51.42%
EPS 3Y-21.18%
EPS 5Y-14.24%
EPS Q2Q%-124.14%
Revenue 1Y (TTM)-22.76%
Revenue growth 3Y-6.54%
Revenue growth 5Y-4.5%
Sales Q2Q%-55.48%

3.2 Future

RE21 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.80% yearly.
The Revenue is expected to grow by 2.60% on average over the next years.
EPS Next Y54.79%
EPS Next 2Y35.97%
EPS Next 3Y24.74%
EPS Next 5Y16.8%
Revenue Next Year-2.13%
Revenue Next 2Y2.87%
Revenue Next 3Y3.42%
Revenue Next 5Y2.6%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RE21.DE Yearly Revenue VS EstimatesRE21.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
RE21.DE Yearly EPS VS EstimatesRE21.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.58 indicates a quite expensive valuation of RE21.
RE21's Price/Earnings ratio is a bit more expensive when compared to the industry. RE21 is more expensive than 76.47% of the companies in the same industry.
When comparing the Price/Earnings ratio of RE21 to the average of the S&P500 Index (28.79), we can say RE21 is valued inline with the index average.
The Price/Forward Earnings ratio is 19.85, which indicates a rather expensive current valuation of RE21.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RE21 indicates a slightly more expensive valuation: RE21 is more expensive than 64.71% of the companies listed in the same industry.
RE21 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.58
Fwd PE 19.85
RE21.DE Price Earnings VS Forward Price EarningsRE21.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RE21 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.43
RE21.DE Per share dataRE21.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RE21's earnings are expected to grow with 24.74% in the coming years.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y35.97%
EPS Next 3Y24.74%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.37%, RE21 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.51, RE21 has a dividend in line with its industry peers.
RE21's Dividend Yield is a higher than the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 3.37%

5.2 History

The dividend of RE21 has a limited annual growth rate of 1.50%.
Dividend Growth(5Y)1.5%
Div Incr Years1
Div Non Decr Years2
RE21.DE Yearly Dividends per shareRE21.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

RE21 pays out 155.39% of its income as dividend. This is not a sustainable payout ratio.
RE21's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP155.39%
EPS Next 2Y35.97%
EPS Next 3Y24.74%
RE21.DE Yearly Income VS Free CF VS DividendRE21.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B
RE21.DE Dividend Payout.RE21.DE Dividend Payout, showing the Payout Ratio.RE21.DE Dividend Payout.PayoutRetained Earnings

REDEIA CORP SA

FRA:RE21 (4/24/2025, 7:00:00 PM)

18.96

-0.07 (-0.37%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)04-30 2025-04-30
Inst Owners32.54%
Inst Owner ChangeN/A
Ins Owners5%
Ins Owner ChangeN/A
Market Cap10.26B
Analysts73.91
Price Target19.27 (1.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.37%
Yearly Dividend1.06
Dividend Growth(5Y)1.5%
DP155.39%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-76.82%
Min EPS beat(2)-147.36%
Max EPS beat(2)-6.28%
EPS beat(4)0
Avg EPS beat(4)-48.85%
Min EPS beat(4)-147.36%
Max EPS beat(4)-6.28%
EPS beat(8)2
Avg EPS beat(8)-22.4%
EPS beat(12)5
Avg EPS beat(12)-15.43%
EPS beat(16)8
Avg EPS beat(16)-11.7%
Revenue beat(2)0
Avg Revenue beat(2)-24.23%
Min Revenue beat(2)-45.83%
Max Revenue beat(2)-2.63%
Revenue beat(4)0
Avg Revenue beat(4)-14.78%
Min Revenue beat(4)-45.83%
Max Revenue beat(4)-2.63%
Revenue beat(8)1
Avg Revenue beat(8)-5.1%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.25%
PT rev (3m)-0.79%
EPS NQ rev (1m)-10.94%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.77%
EPS NY rev (3m)-0.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.92%
Valuation
Industry RankSector Rank
PE 30.58
Fwd PE 19.85
P/S 6.44
P/FCF N/A
P/OCF 10.74
P/B 1.99
P/tB 2.2
EV/EBITDA 13.43
EPS(TTM)0.62
EY3.27%
EPS(NY)0.96
Fwd EY5.04%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)1.77
OCFY9.32%
SpS2.95
BVpS9.53
TBVpS8.62
PEG (NY)0.56
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 7.15%
ROCE 5.86%
ROIC 4.57%
ROICexc 4.95%
ROICexgc 5.18%
OM 44.44%
PM (TTM) 23.11%
GM 102.4%
FCFM N/A
ROA(3y)3.9%
ROA(5y)4.28%
ROE(3y)11.26%
ROE(5y)14.12%
ROIC(3y)5.4%
ROIC(5y)6%
ROICexc(3y)5.94%
ROICexc(5y)6.62%
ROICexgc(3y)6.37%
ROICexgc(5y)7.12%
ROCE(3y)6.92%
ROCE(5y)7.7%
ROICexcg growth 3Y-15.65%
ROICexcg growth 5Y-10.59%
ROICexc growth 3Y-14.67%
ROICexc growth 5Y-10.02%
OM growth 3Y-3.37%
OM growth 5Y-3.68%
PM growth 3Y-12.8%
PM growth 5Y-8.28%
GM growth 3Y0.16%
GM growth 5Y0.22%
F-Score6
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.39
Cap/Depr 233.63%
Cap/Sales 67.66%
Interest Coverage 5.71
Cash Conversion 81.66%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.14
Altman-Z 1.34
F-Score6
WACC5.63%
ROIC/WACC0.81
Cap/Depr(3y)169.97%
Cap/Depr(5y)143.18%
Cap/Sales(3y)48.95%
Cap/Sales(5y)40.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.42%
EPS 3Y-21.18%
EPS 5Y-14.24%
EPS Q2Q%-124.14%
EPS Next Y54.79%
EPS Next 2Y35.97%
EPS Next 3Y24.74%
EPS Next 5Y16.8%
Revenue 1Y (TTM)-22.76%
Revenue growth 3Y-6.54%
Revenue growth 5Y-4.5%
Sales Q2Q%-55.48%
Revenue Next Year-2.13%
Revenue Next 2Y2.87%
Revenue Next 3Y3.42%
Revenue Next 5Y2.6%
EBIT growth 1Y-23.31%
EBIT growth 3Y-9.69%
EBIT growth 5Y-8.02%
EBIT Next Year65.31%
EBIT Next 3Y25.96%
EBIT Next 5Y16.81%
FCF growth 1Y73.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.27%
OCF growth 3Y-15.88%
OCF growth 5Y-1.78%